TYMS and non-small cell lung carcinoma: In the previous study, Salnikov et al. [30] found a significant association between the expression of TS and CD133, which represents a marker of tumor-initiating cells in NSCLC, and was co-expression of ABCG2 in subpopulation of NSCLC patients [31].